(Q52576485)
Statements
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A (English)
Robert H Baloh
Emmanouil Zacharioudakis
Jeanne M Rumsey
Justin M Alberti
William C Knight
R Reid Townsend
1 reference
1 reference